HONEA LTD
Company number SC676936 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
HONEA LTD - Analysis Report
Company Number: SC676936
Analysis Date: 2025-07-29 14:03 UTC
Financial Health Assessment: HONEA LTD (as of 31 March 2024)
1. Financial Health Score: D
Explanation:
HONEA LTD shows significant financial distress indicators primarily due to persistent negative net assets (shareholders’ funds) and substantial long-term liabilities exceeding total assets. Despite some improvement in current assets, the overall capital structure is weak, indicating poor financial health. The company is not insolvent yet but displays symptoms that require urgent attention.
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Fixed Assets | £380,380 | Stable investment in long-term assets, showing ongoing capital allocation. |
| Current Assets | £44,663 | Increased from previous year, indicating some improvement in liquidity. |
| Current Liabilities | £467,752 | Very high short-term obligations, far exceeding current assets, a red flag for liquidity risk. |
| Net Current Assets | £44,663 | Positive in 2024 (from negative in prior years), suggesting some short-term liquidity improvement. |
| Total Assets Less Current Liabilities | £425,043 | Indicates value of assets after settling short-term debts, positive and growing. |
| Creditors (Long-term liabilities) | £467,752 | Increased significantly, now outweighing net assets, indicating heavy leverage. |
| Net Assets (Shareholders’ Funds) | £-42,709 | Negative and worsening over the years, indicating the company owes more than it owns. |
| Average Employees | 5 | Small workforce, consistent with micro-company status. |
3. Diagnosis: Financial Symptoms Analysis
Negative Net Assets ("Symptoms of Distress"):
Net assets have deteriorated from -£7,840 in 2021 to -£42,709 in 2024, showing ongoing erosion of equity. This "symptom" signals that liabilities exceed assets, a classic sign of balance sheet weakness.Heavy Long-Term Debt Load ("Overburdened Respiratory System"):
Long-term creditors rose sharply from £256,542 in 2023 to £467,752 in 2024, suggesting increased borrowing or deferred payments. This heavy debt burden is straining financial health and could impair operational flexibility.Improving Current Asset Position ("Improved Pulse"):
Current assets increased to £44,663 in 2024 from £10,408 previously, improving the company’s ability to meet short-term obligations. Positive net current assets in 2024 indicate some recovery in liquidity.Fixed Asset Growth ("Structural Backbone"):
Investment in fixed assets rose modestly, reflecting ongoing capital expenditure or property investment, consistent with the company’s activity in real estate and development.Operating in Micro Entity Category ("Small but Vulnerable"):
The company qualifies as a micro entity, meaning simpler financial reporting but also limited scale to absorb shocks.No Auditor Involvement ("Lack of External Check-up"):
Accounts are unaudited, which limits transparency and external assurance on financial accuracy.
4. Prognosis: Future Financial Outlook
Given current indicators, the company faces a challenging financial future without corrective action:
- The negative net asset position and rising long-term debt suggest risk of insolvency if trends continue.
- However, improvement in current assets and net current assets is a positive sign, indicating some recovery of liquidity.
- The company’s industry in real estate and development can be capital intensive but also offers potential for asset appreciation if managed well.
- Without intervention, the financial strain ("symptoms") are likely to worsen, possibly leading to financial distress or insolvency procedures.
5. Recommendations: Prescriptions for Financial Wellness
Debt Restructuring and Reduction:
Negotiate with lenders to restructure long-term liabilities, extend repayment terms, or reduce debt burden. Aim to bring long-term debt in line with asset base to relieve financial strain.Enhance Liquidity Management:
Maintain or increase current assets (cash, receivables) to ensure short-term obligations can be met without stress. Consider tighter credit control and efficient working capital use.Capital Injection or Equity Boost:
Explore options for new equity investment to restore positive net assets and strengthen the capital base. This could improve solvency ratios and investor confidence.Cost Control and Operational Efficiency:
Review operational expenses to improve profitability, reduce cash burn, and improve reserves. Given small employee base, focus on productivity and cost management.Engage External Financial Advice and Audit:
Consider professional financial advisory and voluntary audit to gain clearer insight and build stakeholder trust.Monitor and Report Regularly:
Keep close monitoring of key financial ratios and cash flow. Early detection of worsening symptoms is critical.
Summary Table of Vital Signs Interpretation
| Vital Sign | Condition | Action |
|---|---|---|
| Negative Net Assets | Critical | Equity strengthening needed |
| High Long-Term Debt | Critical | Debt restructuring required |
| Improving Current Assets | Positive | Maintain liquidity focus |
| Fixed Assets Growth | Neutral | Monitor asset utilization |
| Micro Entity Status | Limited scale | Be cautious with expansion |
Sign in to generate a free AI analysis of this company — no password needed, just an email link.